Back to search
FDAFDA · Food and drugs·Recall number D-0294-2026

Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02

Published January 28, 2026 · Recall initiated: January 16, 2026

Summary

FDA records drug Class II recall D-0294-2026, published January 28, 2026 and initiated January 16, 2026. Recalling firm: Specialty Process Labs LLC; Status: Ongoing; Reported quantity: 58 gms; Lot: Lot #H22254-1XV; Exp. 01/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Specialty Process Labs LLC
Distributor
U.S. Nationwide
Lot
Lot #H22254-1XV; Exp. 01/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02 recalled?

Yes. FDA published recall D-0294-2026 on January 28, 2026. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter